CI Brunswick Fund
Our archive holds 4 letters from CI Brunswick Fund, behind 5 investment theses. Every quote below is copied verbatim from the letter it came from.
Theses · 5
- September 2025
Deterra Royalties is a pure-play ASX-listed royalty company providing exposure to BHP’s iron ore operations with limited competition and high-quality cash flows, purchased at attractive valuation.
Read the full thesis - September 2025
Origin Energy has a strategically advantaged Energy Markets segment with gas peakers, battery pipeline, cost-to-serve edge, and latent value in Octopus and Kraken investments.
Read the full thesis - September 2025
WiseTech Global operates a sticky logistics software platform and expanded its TAM through the E2open acquisition, offering significant growth and value latency opportunities.
Read the full thesis - March 2025
Ryman Healthcare is positioned for future growth due to significant management changes and a reset balance sheet, despite facing challenges from a recent decline in its business model.
Read the full thesis - December 2024
HMC Capital is positioned for significant growth, aiming to increase its AUM from ~$17.5bn to ~$50bn over the next 3-5 years, leveraging its strong management team and diverse investment platforms.
Read the full thesis
Letter archive · 4
Funds · 2
- CI Australian Equities Fund3
- CI Brunswick Fund1
Get CI Brunswick Fund’s next letter the day it lands
We track CI Brunswick Fund alongside hundreds of other managers, read every letter, and pull out what they bought and sold. Warren AI reads the whole archive for you.
View plans→